Business Wire

Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin

Share

Results from a real-world clinical study conducted in China, to be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Congress, reveal that modern lifestyles and environmental triggers significantly impact individuals with sensitive skin1 Data show that people with sensitive skin living in modern environments have higher levels of inflammation compared to those living traditional, less stressful lifestyles1 This first-of-its-kind study was conducted by Galderma’s Global Sensitive Skincare Faculty (GSSF) as part of the company’s commitment to transforming the understanding and care of sensitive skin1

Galderma today announced new data from a first-of-its-kind real-world clinical study conducted in China assessing the biological impact of different lifestyles and their associated environmental factors on individuals with sensitive skin.1 Results from the study, conducted by dermatology experts from Galderma’s Global Sensitive Skincare Faculty (GSSF), will be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Congress on Friday, September 19. The findings provide compelling evidence that modern, urban lifestyles are associated with worsened skin health in people with sensitive skin.1

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250916245806/en/

Sensitive skin affects up to 70% of people globally – a figure that has risen by 68% over the past two decades – yet it remains widely overlooked and under-studied.2,3 As more people live fast-paced lives in densely populated urban cities, growing evidence links modern lifestyle factors, such as pollution, chronic stress, and poor sleep quality, to worsening skin health.1,4,5 To explore this connection, the GSSF – a global network of dermatology experts dedicated to advancing sensitive skin research and education – launched a real-world study examining the biological impact of urban living on sensitive skin.

 

“This clinical study delivers compelling biological evidence that sensitive skin responds differently and more intensely to the pressures of modern living. These findings validate what many clinicians observe but rarely see quantified: that pollution, stress, and poor sleep can visibly and measurably aggravate sensitive skin. Through this research, Galderma’s Global Sensitive Skincare Faculty is working to elevate sensitive skin from a subjective complaint to a scientifically understood condition, helping pave the way for better diagnosis, education, and care.”

 

AARON FARBERG, MD

DERMATOLOGIST AND MOHS SURGEON

BAYLOR SCOTT & WHITE HEALTH, UNITED STATES

 

 

The clinical study enrolled 150 women from China aged 35–50, divided into three equal groups: individuals with sensitive skin living in modern, urban environments; individuals with sensitive skin living in traditional, less urbanized settings; and individuals with non-sensitive skin living in modern environments.1 Participants in modern environments experienced higher pollution, stress, and poorer sleep compared to those in traditional settings.1 The study compared skin health across these groups to assess the impact of both lifestyle and skin sensitivity.1

Modern living leaves a mark
Results from a tape-stripping analysis of the outermost layer of the skin (the stratum corneum) reveal that sensitive skin faces a triple threat: inflammation, oxidative stress, and environmental damage.1

The study revealed significant biological differences in people with sensitive skin; people living in modern environments exhibited three times more inflammation than those in traditional environments, as evidenced by elevated levels of the inflammatory marker, prostaglandin E2.1 Inflammation plays a key role in sensitive skin by activating immune responses that lead to redness, discomfort, and barrier disruption, making the skin more reactive to environmental stressors.1

The findings also point to oxidative stress – a biological response to environmental stressors like UV exposure and pollution which triggers skin aging – playing a central role in sensitive skin.1 Individuals with sensitive skin in modern environments showed a 16% increase in oxidative stress markers compared to non-sensitive skin, indicating an exaggerated response that may accelerate skin damage and compromise long-term skin health.1 Notably, consistently high oxidative stress levels were observed in sensitive skin regardless of lifestyle, suggesting that oxidative stress may be a core driver of sensitive skin.1

In addition, a higher level of dark spots commonly associated with photoaging was observed in sensitive skin, providing visible evidence of the long-term impact of environmental stressors on skin integrity and appearance.1

Taken together, these findings underscore the profound influence of environmental factors on sensitive skin, particularly in modern urban settings.1 The combination of heightened inflammation, persistent oxidative stress, and visible signs of damage points to a biologically distinct skin profile that is more vulnerable to internal and external triggers.1

Full results from the study will be presented during the GSSF industry hub titled, “Sensitive skin syndrome: A rising phenomenon linked to modern lifestyles and environmental changes” on Friday, September 19 from 11:15 AM - 12:00 PM CET, Hub 2.

Galderma’s mission to improve the lives of those with sensitive skin is reflected in its robust presence at EADV, where the company will also present its latest sensitive skin research across five abstracts, and host Meet the Expert sessions dedicated to its flagship gentle skincare brand, Cetaphil®, at the company’s booth (#EO1). By fostering education and supporting innovative research initiatives, Galderma is helping to transform the field of dermatology and deliver meaningful solutions for people living with sensitive skin.

More information about Galderma’s activities at EADV can be found here.

About Galderma's Global Sensitive Skincare Faculty (GSSF)
The GSSF is a pioneering international initiative dedicated to advancing the understanding, diagnosis, and care of sensitive skin. Bringing together leading dermatology experts from around the world, GSSF conducts inclusive, science-led research to explore factors that contribute to the rise and severity of sensitive skin conditions, such as modern living and climate change. Through landmark studies like the largest-ever epidemiological survey on sensitive skin, GSSF is uncovering the biological realities of sensitive skin across diverse populations. Its mission is to elevate sensitive skin from a subjective complaint to a scientifically recognized condition, driving innovation, education, and improved dermatological outcomes globally.

About Galderma
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

References

  1. Friedman A. Sensitive skin syndrome: A rising phenomenon linked to modern lifestyles and environmental changes. Presented as an industry hub at the European Academy of Dermatology and Venereology Congress; September 17-20, 2025; Paris, France.
  2. Richters R, et al. What Is Sensitive Skin? A Systematic Literature Review of Objective Measurements. Skin Pharmacol Physiol. 2015;28,75-83. doi:10.1159/000363149.
  3. Vidal S, et al. Defining the Prevalence, Clinical Characteristics, and Demographic Influences on Patients with Sensitive Skin Syndrome: Insights from the Largest Global Survey of Sensitive Skin. Poster presented at the EADV Congress; September 17-20, 2025; Paris, France
  4. Prescott SL, et al. The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. WAO Journal. 2017;22,10(1):29. doi:10.1186/s40413-017-0160-5.
  5. Chen X, et al. A review of factors influencing sensitive skin: an emphasis on built environment characteristics. Front. Public Health. 2023;11,1269314. doi:10.3389/fpubh.2023.1269314.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250916245806/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”8.11.2025 07:00:00 CET | Press release

OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group’s vision and growth strategies through 2030, which are disclosed on our corporate website. Overview of the “Medium-Term Roadmap SF 2nd Stage” Since April 2024, OMRON has been implementing a Structural Reform Program “NEXT 2025” aimed at rebuilding our foundation for profitability and growth. With the completion of this Program in September 2025, we have shifted into a growth phase and formulated a new Roadmap looking ahead to 2030. This Roadmap identifies Business Portfolio Restructuring as a core strategy. We have defined Thirteen Focus Businesses to drive the Group’s future growth. By accelerating our selection and concentration efforts, we aim to build a “distinctive” business portfolio that maximizes overall Group growth. Furthermore, to maximize the growth potential of our Focus Busines

26th UN Tourism General Assembly kicks off in Riyadh7.11.2025 22:13:00 CET | Press release

UN Tourism marks 50 years of global cooperation as leaders from across the industry gather to shape the future of tourism. His Excellency Ahmed Al Khateeb, Minister of Tourism – “The Kingdom will play an integral part in ensuring one of the world’s most powerful generators of jobs and GDP grows in harmony with the Sustainable Development Goals.” UN Tourism Secretary-General ZurabPololikashvili – “The UN Tourism General Assembly brings together tourism leaders from across the world to set the agenda and build a more innovative and inclusive sector. From Riyadh, we will set the agenda for tourism for the years ahead.” The 26th session of the UN Tourism General Assembly opened today in Riyadh, marking a historic first for the Gulf Cooperation Council (GCC) region and the largest Assembly since UN Tourism was founded 50 years ago. Around 160 delegations from member states including ministers, senior officials, and leaders from across industry and civil society are coming together to celebr

Xsolla Partners With Deloitte Turkiye and Lorien Accelerator as Category Sponsor for Gaming Awards at Fast 50 Türkiye 2025 Program7.11.2025 19:11:00 CET | Press release

Celebrating Turkey’s Gaming Industry with High-Impact Sponsorship and Industry Panel Xsolla, a leading global video game commerce company that helps developers launch, grow, and monetize their games, is proud to announce its sponsorship of the Gaming Awards segment at the Deloitte Technology Fast 50 Türkiye 2025 Program, organized in collaboration with Lorien Accelerator. The event will take place on December 10, 2025, and will recognize Turkey’s top high-growth companies across various industries, with a special focus on the dynamic gaming sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251107671030/en/ Graphic: Xsolla As the Gaming Awards category sponsor, Xsolla will receive significant brand exposure through prominent logo placements across all event materials, including digital platforms, official event signage, and other promotional materials. In addition to this visibility, Xsolla’s participation includes an ex

Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy7.11.2025 17:00:00 CET | Press release

− Phase 1b, Open-Label Study Follow Up Shows Stable Kidney Function (eGFR) in Patients Treated with Investigational Mezagitamab Through Week 96 – 18 Months After Last Dose1− Rapid Reductions in Proteinuria and Serum Gd-IgA1 Levels Were Sustained Through Week 961− No Serious Adverse Events or Opportunistic Infections Were Observed Through Week 961− Takeda Initiated Pivotal Phase 3 Clinical Trials Evaluating Mezagitamab in Primary IgA Nephropathy and Immune Thrombocytopenia with Patient Enrollment Ongoing Takeda (TSE:4502/NYSE:TAK) today announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab (TAK-079), an anti-CD38 monoclonal antibody with disease-modifying potential, in primary immunoglobulin A (IgA) nephropathy. Data from the study showed that kidney function (eGFR) remained stable in patients with IgA nephropathy through Week 96 – up to 18 months after the last mezagitamab dose.1 The results were presented at the American Society o

Oremus Corporate Services Expands into Europe with Launch in Finland7.11.2025 16:23:00 CET | Press release

CEO, Lalit Ananth Chawla, to Attend Slush 2025 in Helsinki Oremus Corporate Services Private Limited, a multinational Finance and Accounting Advisory firm having its offices in the USA, India and the UK, has announced the extension of its services to Finland, marking the company’s foray into the European market. With over two decades of expertise in accounting, payroll, tax compliance, and advisory services, Oremus has earned trust as a technology-driven finance partner serving clients across geographies. Oremus is an ISAE 3402, ISO 27001, GDPR & DPDP Compliant Company, adhering to International Quality and Security Standards. “Finland isn’t just a new market for us — it’s the gateway to meaningful, growth-driven partnerships across Europe”. said Lalit Ananth Chawla, CEO of Oremus. Having established a strong reputation for delivering reliable Accounting and Advisory solutions to scale-ups and growing businesses, we seek to collaborate with like-minded firms and investors to build a tr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye